Repository logo
 
Publication

Artemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysis

dc.contributor.authorPatrocínio-Jesus, R
dc.contributor.authorCunha, J
dc.contributor.authorTrigo, D
dc.contributor.authorFlor-de-Lima, B
dc.contributor.authorPacheco, P
dc.date.accessioned2019-05-13T14:41:34Z
dc.date.available2019-05-13T14:41:34Z
dc.date.issued2019
dc.description.abstractThe combination of artemether/lumefantrine is indicated for the treatment of acute uncomplicated Plasmodium falciparum malaria. There have been no clinical trials to assess the efficacy of this medication in patients with renal impairment. While it is unlikely that artemether/lumefantrine would be removed during dialysis, clinical experience regarding drug use in this setting is limited. In this article, the authors report successful treatment of Plasmodium malariae malaria on a patient with end-stage kidney disease undergoing hemodialysis.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationCase Rep Med. 2019 Feb 12;2019:1326171pt_PT
dc.identifier.doi10.1155/2019/1326171pt_PT
dc.identifier.issn1687-9635
dc.identifier.urihttp://hdl.handle.net/10400.10/2240
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherHindawipt_PT
dc.relation.publisherversionhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390258/pdf/CRIM2019-1326171.pdfpt_PT
dc.subjectMalariapt_PT
dc.subjectDrug combination artemether, lumefantrinept_PT
dc.subjectHemodialysispt_PT
dc.titleArtemether/Lumefantrine for the Treatment of P. malariae in a Patient on Hemodialysispt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceNew York, NYpt_PT
oaire.citation.titleCase reports in medicinept_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Case Rep Med. 2019.pdf
Size:
984.73 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: